u 74389f has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flickinger, JC; Kondziolka, D; Lunsford, LD; Martinez, AJ; McLaughlin, MR; Mori, Y | 1 |
| Deliorman, S; Durmaz, R; Erol, K; Isiksoy, S; Tel, E; Uyar, R | 1 |
2 other study(ies) available for u 74389f and Glioma
| Article | Year |
|---|---|
Beneficial effects of the radioprotectant 21-aminosteroid U-74389G in a radiosurgery rat malignant glioma model.
Topics: Animals; Brain; Brain Edema; Brain Neoplasms; Drug Evaluation, Preclinical; Glioma; Male; Pregnatrienes; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiosurgery; Rats; Rats, Sprague-Dawley | 1999 |
Antiproliferative properties of the lazaroids U-83836E and U-74389G on glioma cells in vitro.
Topics: Animals; Antioxidants; Brain Neoplasms; Cell Division; Chromans; Dose-Response Relationship, Drug; Glioblastoma; Glioma; Humans; Inhibitory Concentration 50; Piperazines; Pregnatrienes; Rats; Tumor Cells, Cultured | 1999 |